DNA ploidy and proliferation have been shown in several studies to be prognostic markers for prostate cancer. Flow cytometry (FCM) is often used in the determination of ploidy and proliferation.

In total, ploidy abnormalities were detected in 1.15% (CI 95% 1.0-1.2) of embryos after clinical pre-implantation genetic testing, of which 0.9% were triploidy (embryos with an extra set of ...

Purpose: DNA ploidy has consistently been found to be a correlate of prostate cancer patient outcome. However, a minority of studies have used pretreatment diagnostic material and have involved ...

The 5-year overall survival (OS) rate by ploidy status was 73% in hyperdiploid patients as compared with 33% and 25% in diploid and tetraploid patients, respectively (P = .0012). A striking difference ...

He said, “DNA Wellness is planning to invest Rs 200 crore to establish some 100 dedicated CERViSure laboratories across India in a phased manner by 2027.

Abstract. When differentiated lineages come into contact, their fates depend on demographic and reproductive factors. These factors have been well-studied in taxa of the same ploidy, but less is known ...